Fundraising Fox

Michal Silverberg

Investor

Managing Director at Novartis Venture Fund

Boston, Massachusetts

Writes $5M – $10M checks · typically $7.5M

Contact· self-published, not guessed

Experience

  1. novartis venture fundManaging Directorcurrent2017 — present
  2. Takeda Ventures, Inc.Senior Partner2014 — 2017
  3. Novo NordiskSenior Director Business Development and New Product Commercialization2007 — 2013
  4. OSI PharmaceuticalsManager Business Development2006 — 2007
  5. MGVS (Multi Gene Vascular Systems)VP Business Development and Operation2003 — 2006

Skills & more

Clinical Development14Biotechnology15Pharmaceutical Industry23

From Michal's professional profile.

Deals · 1

ImmPACT Bio USA Inc.Board seat

via Novartis Venture Fund · filed Aug 2020 · $5.5M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Novartis Venture Fund

Frequently asked questions

Who is Michal Silverberg?
Managing Director at Novartis Venture Fund
Where does Michal Silverberg work?
Michal Silverberg is Managing Director at Novartis Venture Fund.
What check size does Michal Silverberg write?
Michal Silverberg typically writes checks of $5M – $10M.
What boards does Michal Silverberg sit on?
Michal Silverberg holds tracked board seats at ImmPACT Bio USA Inc..
Where did Michal Silverberg go to school?
Michal Silverberg studied at Columbia University (MA, Biotechnology); Tel Aviv University (MBA); University of Haifa (BA, Economics & Business).

Same school

Shared employers